Oral Bivalent GI.1/GII.4 Norovirus Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Oral Bivalent GI.1/GII.4 Norovirus Vaccine, covering 2026-04-15 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Vaxart's Oral Bivalent GI.1/GII.4 Norovirus Vaccine in Healthy Lactating Females and Their Nursing Infants [Phase 1]